BRIEF published on 03/27/2025 at 19:17, 2 months 6 days ago Advicenne Reports Solid Growth and Future Plans for 2025 Cash Flow Improvement 2025 Outlook Advicenne Financial Results Sibnayal Sales Growth ADV7103 Regulatory Progress
BRIEF published on 03/27/2025 at 19:17, 2 months 6 days ago Advicenne annonce une croissance solide et des projets futurs pour 2025 Amélioration Des Flux De Trésorerie Perspectives 2025 Résultats Financiers D'Advicenne Croissance Des Ventes De Sibnayal Progrès Réglementaires ADV7103
PRESS RELEASE published on 03/27/2025 at 19:12, 2 months 6 days ago Inside Information / News release on accounts, results Advicenne reports successful commercial performance of Sibnayal® in Europe, with total product sales up 9.4% to €4.9m. Major strides in US development with NDA filing expected in Q3 2025 Financial Results Advicenne Commercial Performance Sibnayal US Development
PRESS RELEASE published on 03/27/2025 at 19:12, 2 months 6 days ago Informations privilégiées / Communiqué sur comptes, résultats Advicenne annonce ses résultats annuels 2024 avec un chiffre d'affaires en hausse de 9,4% grâce à Sibnayal® en Europe; avancées réglementaires majeures aux Etats-Unis Chiffre D'affaires Résultats Annuels États-Unis Advicenne Sibnayal
BRIEF published on 10/01/2024 at 07:05, 8 months 1 day ago Advicenne progresse aux États-Unis avec des avis positifs de la FDA sur ADV7103 FDA Advicenne ADV7103 ATRd Cystinurie
BRIEF published on 10/01/2024 at 07:05, 8 months 1 day ago Advicenne Advances in US with Positive FDA Reviews for ADV7103 FDA ADV7103 ATRd Advicenna Cystinuria
PRESS RELEASE published on 10/01/2024 at 07:00, 8 months 1 day ago Informations privilégiées / Autres communiqués Advicenne franchit des étapes majeures aux Etats-Unis pour ADV7103 avec des avis favorables de la FDA, ouvrant des opportunités partenariales, simplifiant les démarches réglementaires et cliniques FDA Développement États-Unis Partenaires Advicenne
PRESS RELEASE published on 10/01/2024 at 07:00, 8 months 1 day ago Inside Information / Other news releases Advicenne achieves major milestones in the US with positive FDA opinions on ADV7103, accelerating partnership outlook for commercialization, preparing for clinical development in cystinuria, and seeking commercial partners Commercialization Advicenne ADV7103 Cystinuria FDA Opinions
BRIEF published on 05/15/2024 at 09:07, 1 year ago Advicenne Shareholders Approve Board-Supported Resolutions at General Meeting Euronext Growth Paris Pharmaceutical Industry General Meeting Advicenne Rare Renal Diseases
BRIEF published on 05/15/2024 at 09:07, 1 year ago Les actionnaires d'Advicenne approuvent les résolutions soutenues par le conseil d'administration lors de l'assemblée générale Assemblée Générale Euronext Croissance Paris Industrie Pharmaceutique Conseille Maladies Rénales Rares
Published on 06/02/2025 at 22:45, 12 minutes ago Nepra Foods Inc. Reports Record Revenue from Major Customer and Exceptional Q4 2025 Growth
Published on 06/02/2025 at 22:30, 27 minutes ago Reyna Silver Corp. Announces Resignation of Director
Published on 06/02/2025 at 15:00, 7 hours 57 minutes ago Newsmax to Participate in Maxim Group's "2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow" Virtual Conference
Published on 06/02/2025 at 15:00, 7 hours 57 minutes ago 1933 Industries Announces the Completion of the Purchase of 9% Interest of Cultivation and Production Subsidiary
Published on 06/02/2025 at 14:55, 8 hours 2 minutes ago Tectonic Metals Launches Largest Drill Program to Date with Three Drill Rigs at Flat Gold Project, Alaska
Published on 06/02/2025 at 22:48, 9 minutes ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 06/02/2025 at 22:42, 15 minutes ago EQS-Adhoc: PIERER Mobility AG: Changes to the Supervisory Board
Published on 06/02/2025 at 22:00, 57 minutes ago Abivax Presents First Quarter 2025 Financial Results
Published on 06/02/2025 at 22:00, 57 minutes ago Abivax présente ses résultats financiers du premier trimestre 2025
Published on 06/02/2025 at 20:11, 2 hours 46 minutes ago Shareholders of flatexDEGIRO AG elect new Supervisory Board and approve dividend of 4 cents per share
Published on 06/02/2025 at 18:43, 4 hours 14 minutes ago Monthly disclosure of the total number of shares and voting rights - May 2025
Published on 06/02/2025 at 18:43, 4 hours 14 minutes ago Déclaration mensuelle des actions et droits de vote – Mai 2025
Published on 06/02/2025 at 18:20, 4 hours 36 minutes ago Reporting on share buyback transactions carried out between May 22 and May 23, 2025
Published on 06/02/2025 at 18:20, 4 hours 36 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 22 et 23 mai 2025
Published on 06/02/2025 at 18:00, 4 hours 57 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
